Alterity Therapeutics (ATHE) Current Assets (2015 - 2025)

Alterity Therapeutics has reported Current Assets for 11 years, with the latest figure at $37.3 million in Q4 2025.

• For the quarter ending Q4 2025, Current Assets rose 446.92% year-over-year to $37.3 million; the trailing twelve-month figure through Dec 2025 stood at $37.3 million (up 446.92% YoY), and the FY2025 full-year result was $29.4 million, up 134.16% from the prior year.
• Current Assets for Q4 2025 stood at $37.3 million, up from $29.4 million in the prior quarter.
• The five-year high for Current Assets was $37.3 million in Q4 2025, with the low at $270487.7 in Q2 2023.
• Average Current Assets over 5 years is $21.0 million, with a median of $23.8 million recorded in 2021.
• Year-over-year, Current Assets slumped 99.08% in 2023 and jumped 4538.2% in 2024.
• Tracing ATHE's Current Assets over 5 years: stood at $32.7 million in 2021, then slumped by 33.24% to $21.8 million in 2022, then plunged by 34.38% to $14.3 million in 2023, then sank by 52.35% to $6.8 million in 2024, then surged by 446.92% to $37.3 million in 2025.
• The last three Current Assets figures came in at $37.3 million (Q4 2025), $29.4 million (Q2 2025), and $6.8 million (Q4 2024), per Business Quant data.

Peer Comparison